去势抵抗性前列腺癌进展时间的预测因素分析

纪光杰, 黄聪, 宋刚^△, 李学松, 宋毅, 周利群

Predictive factor analysis of time to progression of castration-resistant prostate cancer after androgen deprivation therapy

JI Guang-jie, HUANG Cong, SONG Gang^△, LI Xue-song, SONG Yi, ZHOU Li-qun

不同分组CRPC进展时间的生存曲线分析 A, time to PSA nadir (≤9 months vs . >9 months); B, with or without metastasis; C, risk groups (low risk, intermediate risk, and high risk); D, PSA decline velocity [≤11 μg/(L·month) vs . >11 μg/(L·month)]. Abbreviations as in Table 1 .